HOW LONG DOES
TARGETED THERAPY WORK?
For most solid tumours, targeted therapy eventually stops working. Duration varies enormously by cancer type, drug, and mutation. Understanding expectations -- and having the next-step plan ready -- matters from the start.
Targeted Therapy Duration by Drug and Cancer Type
EGFR-mutant NSCLC -- Osimertinib (FLAURA trial)
ALK-rearranged NSCLC -- Lorlatinib
Chronic-phase CML -- BCR-ABL inhibitors
BRAF V600-mutant Melanoma -- BRAF/MEK combination
HR+ Metastatic Breast Cancer -- CDK4/6 inhibitors
Frequently Asked Questions
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Questions About Your Targeted Therapy Duration and Next Steps?
CancerFax reviews your treatment status and connects you with oncologists who can explain what the response trajectory looks like for your specific drug and mutation.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.